116 related articles for article (PubMed ID: 37655980)
1. The S100 calcium-binding protein A6 plays a crucial role in hepatic steatosis by mediating lipophagy.
Du Q; Zhu T; Wen G; Jin H; An J; Xu J; Xie R; Zhu J; Yang X; Zhang T; Liu Q; Yao S; Yang X; Tuo B; Ma X
Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37655980
[TBL] [Abstract][Full Text] [Related]
2. Liver-Derived S100A6 Propels β-Cell Dysfunction in NAFLD.
Dogra S; Das D; Maity SK; Paul A; Rawat P; Daniel PV; Das K; Mitra S; Chakrabarti P; Mondal P
Diabetes; 2022 Nov; 71(11):2284-2296. PubMed ID: 35899967
[TBL] [Abstract][Full Text] [Related]
3. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
[TBL] [Abstract][Full Text] [Related]
4. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
Elife; 2023 Aug; 12():. PubMed ID: 37580962
[TBL] [Abstract][Full Text] [Related]
6. Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins.
Nowotny M; Spiechowicz M; Jastrzebska B; Filipek A; Kitagawa K; Kuznicki J
J Biol Chem; 2003 Jul; 278(29):26923-8. PubMed ID: 12746458
[TBL] [Abstract][Full Text] [Related]
7. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
[TBL] [Abstract][Full Text] [Related]
8. S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis.
Dong XH; Dai D; Yang ZD; Yu XO; Li H; Kang H
World J Gastroenterol; 2021 May; 27(17):1973-1992. PubMed ID: 34007134
[TBL] [Abstract][Full Text] [Related]
9. Current view on cellular function of S100A6 and its ligands, CacyBP/SIP and Sgt1.
Filipek A; Leśniak W
Postepy Biochem; 2018 Oct; 64(3):242-252. PubMed ID: 30656909
[TBL] [Abstract][Full Text] [Related]
10. S100A6 is a positive regulator of PPP5C-FKBP51-dependent regulation of endothelial calcium signaling.
Haldar B; Hamilton CL; Solodushko V; Abney KA; Alexeyev M; Honkanen RE; Scammell JG; Cioffi DL
FASEB J; 2020 Feb; 34(2):3179-3196. PubMed ID: 31916625
[TBL] [Abstract][Full Text] [Related]
11. The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling.
Teng F; Jiang J; Zhang J; Yuan Y; Li K; Zhou B; Zhou X; Liu W; Zhang P; Liu D; Zheng M; Lu Y; Zhang H
Metabolism; 2021 Apr; 117():154725. PubMed ID: 33571540
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
Gao L; Wang PX; Zhang Y; Yu CJ; Ji Y; Wang X; Zhang P; Jiang X; Jin H; Huang Z; Zhang ZR; Li H
J Hepatol; 2016 Jul; 65(1):125-136. PubMed ID: 27032381
[TBL] [Abstract][Full Text] [Related]
13. S100A6 represses Calu-6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis.
Wang T; Han S; Du G
Cell Biochem Funct; 2021 Aug; 39(6):771-779. PubMed ID: 34008212
[TBL] [Abstract][Full Text] [Related]
14. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.
Onsurathum S; Haonon O; Pinlaor P; Pairojkul C; Khuntikeo N; Thanan R; Roytrakul S; Pinlaor S
Tumour Biol; 2018 Apr; 40(4):1010428318767195. PubMed ID: 29629840
[TBL] [Abstract][Full Text] [Related]
15. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
16. Interaction of S100A6 with Target Proteins In Vitro and in Living Cells.
Sakane K; Yamaguchi F; Tsuchiya M; Kondo R; Kanayama N; Magari M; Hatano N; Kobayashi R; Tokumitsu H
Methods Mol Biol; 2019; 1929():367-377. PubMed ID: 30710285
[TBL] [Abstract][Full Text] [Related]
17. The Protective Effects of Cinnamyl Alcohol Against Hepatic Steatosis, Oxidative and Inflammatory Stress in Nonalcoholic Fatty Liver Disease Induced by Childhood Obesity.
Dai Y; Zhang X; Xu Y; Wu Y; Yang L
Immunol Invest; 2023 Nov; 52(8):1008-1022. PubMed ID: 37962037
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of S100A6 in patients with endometriosis and its role in ectopic endometrial stromal cells.
Peng Y; Lin J; Ma J; Lin K; Xu K; Lin J
Gynecol Endocrinol; 2018 Sep; 34(9):815-820. PubMed ID: 29544367
[TBL] [Abstract][Full Text] [Related]
19. Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis.
Park J; Rah SY; An HS; Lee JY; Roh GS; Ryter SW; Park JW; Yang CH; Surh YJ; Kim UH; Chung HT; Joe Y
Metabolism; 2023 Apr; 141():155516. PubMed ID: 36773805
[TBL] [Abstract][Full Text] [Related]
20. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy.
Liu K; Qiu D; Liang X; Huang Y; Wang Y; Jia X; Li K; Zhao J; Du C; Qiu X; Cui J; Xiao Z; Qin Y; Zhang Q
Autophagy; 2022 Apr; 18(4):860-876. PubMed ID: 34382907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
